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Abstract

To study the metabolic consequences of coba1 amin-folate
interactions in vitamin Bi2 deficiency, a simple in vitro assay of
folate-dependent I^C-formate incorporation into 1^-L-serine by
peripheral leukocytes has been developed and applied to B]2 deficient
and folate deficient patients.
In five vitamin B12 deficient patients,
incorporation was significantly reduced, suggesting that cobalamin
deficiency depletes the intracellular pool of free tetrahydrofolate,
required in this reaction as carrier of the I^C-formate.
The possible
mechanisms by which this might occur are discussed.
No defect in
I^C-formate incorporation into 1^C-L-serine was observed in two folate
deficient patients, but the significance of this finding is speculative
because of the small number of patients studied.
Leukocytes from
vitamin B12 deficient patients also demonstrated a reduced capacity to
oxidize 1^C-3-propionate to 1^C02 but normal 1^C02 production from
1^C-1 ,4 -succinic acid.
These observations suggest a block in the
oxidative catabolism of propionate at the B12~dependent methylmalonyl
CoA mutase step.
No defects in propionate metabolism were observed
in the folate deficient patients.
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Vitamin B^2

(any form)

CN-B12 :

Cyanocobalamin

dA~B]2:

51-deoxyadenosy1coba1 amin

CH^-Bi 2 •

Methylcobalamin
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PGA:

folic acid, pteroy1glutamic acid

FH^:

tetrahydrofolic acid

N5-CH3-FH4:
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n5n10-ch2-FH2+ :

N5NlO-methylenetetrahydrofolate

[\|5n 10-CH = FH/t:

N5N10-metheny1tet rahyd rofolate

N5-CH0-FH^:

N^-formy1tetrahydrofolate, folinic acid

N^-CHO-FH^:
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RNA:
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INTRODUCTI ON

From little-understood disorders of insidious onset, unknown
etiology, and usually fatal outcome, the megaloblastic anemias have
evolved over the past fifty years

into a well-defined group of

eminently treatable diseases due to deficiency of vitamin
folates.

or

They have been the subject of increasingly sophisticated in¬

vestigations, the results of which have had broad
understanding of regulatory mechanisms

in intermediary metabolism

both at the cellular and whole-organism level.
probing, however, fundamental

questions

by which deficiencies of vitamin
The objectives of this paper will

implications for the

In spite of this

remain about the mechanisms

and/or folic acid produce anemia.
be twofold:

first, to explore the

hypotheses which have been advanced to account for the clinical
similarities - and differences - between the syndromes produced by lack
of these essential

nutrients; and second, to review the sti11-unsett1ed

question of what in fact constitutes folate "deficiency", and how it
can best be assessed

in the clinical

setting.

In terms of this

second objective, the results of a study by the author of a recently
developed
presented.

in vitro assay for detecting folate deficiency^ will

be

The data derived from the application of this same assay

to the B12 deficient patient, and of an
dependent methy1ma1ony1

indirect assay of vitamin B^-

CoA mutase activity^ to both the folate and

B^2 deficient patient, will also be presented and discussed

in the

context of present understandings of cobalamin - folate interdependence.

-2-

A comprehensive review of the fascinating but voluminous
literature concerning the historical, clinical, morphologic, genetic,
and

immunologic aspects of the megalob1astic anemias

is beyond the

scope of the present effort, but the field has recently been surveyed
admirably by Chanarin^ and by Harris and Ke11ermeyer.^

3
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VI TAM IN B12

Only five years after Addison's description

in 1855 of what

may have been what we now recognize as pernicous anemia, Austin Flint
offered the following hypothesis concerning its pathogenesis:
I suspect that in these cases there exists degenerative
disease of the glandular tubuli of the stomach. . . . Fatal
anemia must follow an amount of degenerative disease reducing
the amount of gastric juice so far that assimilation of food
is rendered wholly inadequate to the wants of the body. . . .
I shall be ready to claim the merit of this idea when the
difficult and laborious researches of someone have shown it to
be correct.5
As predicted, however,

little progress was made

standing or therapy of the disease until

in either the under-

1926, with Minot and Murphy's0

introduction of an effective dietary treatment.

Castle's studies,7

resulting eventually in the isolation of intrinsic factor from gastric
secretions, the crystallization of cyanocobalamin

in 19^8, and the

elucidation of its structure in 1955, have led to our present under¬
standing of the nature of the missing vitamin, and the means by which
its deficiency can arise

in

individuals with apparently adequate

nutrition.

o

St ructu re°

Crystalline vitamin

consists of a planar tetrapyrrole

nucleus, with three of the rings joined by
the porphyrins.

«x-methene bridges, as

in

In contradistinction to the porphyrins, the ring is

completed by a direct carbon-to-carbon bond between

cx-positions of

-li¬

the

pyrroles designated A and D, and the four bases are partially

reduced.

A trivalent cobalt atom lies at the center of the ring

structure;

four of its six coordinate binding sites are occupied

one plane by the pyrrole nitrogens.

The 5th binds to base nitrogen

of a nucleotide lying "below” the planar ring.
Co-N coordinate bond, the nucleotide, which
benz i mi dazol e base linked by an
phosphate,

In addition to the

is a 5,6,-dimethyl-

<x-glycoside bridge to ribose-3"

is also bound to the tetrapyrrole nucleus through

phosphate group.

This ties

it, through an ami noisopropanol

to a propionic acid side chain of the D ring.
lies a cyano group, which by an
coordinate site of the central
not occur normally in vivo, and

ionic bond
Co atom.

its
linkage,

"Above" the nucleus

is tied to the sixth

Cyanocoba1 amin probably does

in the coenzymatica11y active forms of

the vitamin the sixth Co coordinate site is occupied by a methyl
or by 51-deoxyadenosy1

ribonuc1eoside.

synthesis of the coenzymes
Co®

in

It appears that

group

in vivo

involves progressive reduction of Co'*®

to

before addition of the active substituent at the sixth position.

The structure of one of the
(dA-Bi2)

is

illustrated

coenzymes, 51-deoxyadenosy 1 cobalamin

in Figure 1.

Nutritional Aspects^

Vitamin B^

is synthesized by bacteria through essentially

the same metabolic pathway as are the pyrroles
occur in the plant kingdom, and

in heme.

in the higher animals

It does not

is derived solely

5

-

Figure 1. Structure of 5'-deoxyadenosylcobalamin. From
Harris JW, Kellermeyer RW: The Red Cell. Cambridge:
Harvard University Press, 1970, p 3TT5Y

-
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from dietary sources.

It

is so ubiquitous among many soil organisms

that even domestic water supplies may serve as dietary sources, and
bacterial

contamination of the exclusively vegetarian diets of some

mammals may be sufficient to prevent deficiency.

Animal

food sources

contain significant amounts of the vitamin, the highest concentration
occurring in liver.
dietary

It has been estimated that essentially all

is available for absorption,

maximum daily capacity of the

limited only by the 2-3 meg

intrinsic factor-ileal

receptor

absorption system.

Biochemist ry

The two coenzymes forms of vitamin B^ ate involved in reO

actions which have been grouped by Silber and Moldow0 into two classes.
Those requiring dA-B^ involve hydrogen transfer along a carbon chain,
with reciprocal

movement of a second group in the opposite direction:
R"

H

R — C — C — R"

W 'Hi
H

'

<->

H

H

I

I

R1— C — C— R"

I

I

H

R"

Only one such pathway, the isomerization of L-methylmalonyl
succinyl

CoA, has been convincingly demonstrated

activity of methylmalonyl

in man.

CoA^

CoA to

Decreased

CoA mutase, as measured either by increased

urinary methylmalonic acid excretion^ or by decreased
from leukocyte homogenates

1

production

incubated with ^C(carboxy)-D-methy1ma1ony1

has been reported as an index of the B12 deficiency state in man.

7
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An appreciation of the role played by the other
coenzyme, methylcobal amin
studies
methyl

(CH^-B-^)

in mammalian systems arose from

in rats demonstrating capability for de novo synthesis of the
group of methionine from ^C-formate.^

In 1951, Bennet et al.

reported that the liver-derived factor, permitting growth of rats on a
diet free of labile methyl
cysteine was vitamin B^-^

groups but containing folic acid and homo¬
Additional evidence linking B^ with

methionine biosynthesis was derived from a strain of Escherichia coli
requiring either B^2 or methionine for growth.
that

It was demonstrated

in the presence of cobalamin, the organism synthesized methionine

de novo provided that the medium also supplied homocysteine, folate,
and a source of single-carbon units.Further investigations on
the same organism revealed that the immediate methyl

donor for the

reaction was N^-methy1tetrahydrofolate (N^-CH^-FH^).^

In 1954

Buchanan and co-workers reported a partially purified enzyme preparation
from pig liver, with similar properties and cofactor requirements.
Enzyme activity was found to directly parallel
preparation.

17
'

1 o

’

B^ content of the

Requirements for FADH2 and S-adenosyl methionine

(Met-S-Ad) were also demonstrated, and the latter was shown to serve a
catalytic rather than stoichiometric function
process.

in the methylation

On the basis of these studies the following sequence of re¬

actions has been proposed to take place:
Met-S-Ad

^

HCys-S-Ad

^
fmnh2

FMN

V

fh4

K

N5-CH3-FH^

4/

HCys
t

V
■>Enz-B]
?oxidation?

Met
2

8

-

The precise catalytic role of S-adenosyl

-

methionine remains unclear.

Taylor and Weissbach^ have suggested that a "priming" methylation of
the cobamide prosthetic group of the holoenzyme is
methyl

involved, since

iodide can replace Met-S-Ad in their assay (E_. col i)

system.

They postulate that subsequent regeneration of CH3-B12 with each methyl
group transfer to homocysteine results from stoichiometric amounts of
substrate N^-CH^-FH^.
A coba1 amin-independent methyl transferase active only for
the triglutamate form of N^-CH^-FH^ has been
of E_. col i .^0

Evidence suggesting its presence

been presented,21
systems

but

is unknown.

summarized

identified

in human liver has also

its quantitative significance

in mammalian

The well-established actions of

in Table 1.

roles for the cobalamins

in other strains

coenzymes are

The implications of searches for other metabolic
in man will be discussed later.
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FOLIC ACID

The relationship of an essential

nutrient other than

vitamin Bi2 to the development of megaloblastic anemia began to be
elucidated in 1931, with the recognition of a "pernicious anemia of
pregnancy" occurring in Hindu women.

22

anemia, achlorhydria and neurological

In contrast to Addisonian
signs of posterolateral

degeneration were consistently absent.^3

column

jn addition, these patients

responded with hematologic remissions both to crude - but not purified liver extract, and to "marmite", an autolyzed yeast preparation,
again separating them from patients with classical
The

initial

A and C was

22

pernicious anemia.

hypothesis that chronic dietary deprivation of vitamins
responsible for this form of megaloblastic anemia

2k

was

subsequently shown to be erroneous, but studies of an experimental
megaloblastic anemia in monkeys and many bacteriologic growth studies
were required before folic acid was shown to be the active principle
in the therapy.^

Biochemistry of the Folates

This subject and most other aspects of these compounds have
been exhaustively reviewed recently,
pertinent points will

9 A

and only a summary emphasizing

be attempted here.

The parent compound of the folates
acid

(PGA).

Although

is pteroy1monoglutamic

it functions effectively in supporting growth

2k

-11-

of organisms dependent on folates,

it,

like cyanocoba1 amin,

a stable isolatable form not coenzymatical 1y active
be considered to consist of three portions:
aminobenzoic acid, and L-glutamic acid.

is merely

in vivo.

PGA can

the pteridine, para-

Naturally occurring folates

differ from PGA in three respects.

First, the pteridine nucleus

is

reduced at positions 5,6,7, and 8.

Second, single-carbon units at

different oxidation states are bound covalently to the nitrogens at
positions 5 or 10 or bridged between them.

Third, additional L-glutamyl

residues may be linked to the parent compound through unique peptide
linkages;

i.e.,

glutamate.

tx-amino to the

v-carboxyl

Folates coenzymatica11y active

monoglutamates;

group of the proximal
in man are probably all

food folates are primarily hexa- and heptag1utamates

and are acted on by an enzyme termed "conjugase" to liberate the mono¬
glutamates prior to absorption from the gastrointestinal
Other details of the absorptive process will

be discussed

tract.^7
later.

The

structures of PGA, monoglutamate coenzymes, and the triglutamate are
illustrated

in Figure 2.

Folates function
actions

in a great many one-carbon transfer re¬

in mammalian systems.

Figure 3-

In a general

Their principal

vertible in vivo among formate,

labelled carbon

is readily intercon¬

formaldehyde, serine

purine (2- or 8-carbon), histidine
carbon).

in

sense, this schema simply suggests what has been

confirmed experimentally, that

(methyl

roles are summarized

( ^-carbon),

(imidazole-2-carbon), or methionine

Of key importance to the present discussion

is that,

in mammalian systems, one of these reactions, the methylation of homo¬
cysteine,
earl i er.

is also dependent upon the presence of cobalamin, as discussed

-12-
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Figure 2. Structures of the Folates. Adapted from Harris JW,
Kellermeyer RW: The Red Cell. Cambridge: Harvard University
Press, 1970, p 395.
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Figure 3. Folate-dependent Reactions. The central role of vitamin
B^2
regeneration of free tetrahydrofolate is illustrated. From
Herbert V: Drugs effective in the megaloblastic anemias. The
Phamacological Basis of Therapeutics, Goodman LS, Gilman A eds.
New York: The MacMillan Company, 1970.
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THE ASSESSMENT OF FOLATE DEFICIENCY

Although more than four decades have elapsed since publication
of Wills'
problems

initial

studies of folate deficiency, significant unsettled

remain to confront the clinician attempting to assess folate

nutritional

status.

Indeed, until

Herbert documented the progressive

development of the deficiency syndrome
on a folate-poor diet,

in a normal

there was not general

subject maintained

agreement that megalo¬

blastic anemia could arise solely as a consequence of dietary folate
deprivation.

While this study resolved the above

revealed another;

issue,

it implicitly

if megaloblastic anemia, hematological 1y indistin¬

guishable from that resulting from gastric atrophy, could arise
secondary to folate deprivation, how were the two syndromes to be
distinguished clinically?

Prior to I960, the distinction was made on

the basis of the non-hematologic accompaniments of B1 2 deficiency.
Absence of neuropathy was obviously less than reliable in this regard
since

it was not a universal

deficiency.

accompan i ment of anemia caused by

The sensory neuropathy commonly observed

in alcoholic

patients further diminished the reliability of the neurologic features
as a discriminatory tool.

Achlorhydria, consistently present

Addisonian anemia, was also found to have limited usefulness
differential

in
in the

diagnosis, since it occurred in a significant percentage

of older normal

individuals.

The demonstration of "histamine-fast"

achlorhydria and achylia gastrica were found to have greater
diagnostic value, but at the expense of considerable discomfort to the
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patient.

In summary, "folate deficiency" was considered a diagnosis

made primarily by exclusion.
Attempts to refine the clinician’s ability to differentiate
from folate deficiency have been directed along five major avenues.
Each of these will

be discussed below.

Morphologic Distinctions between

and Folate Deficiencies

From time to time, various aspects of the peripheral

or

marrow morphology have been touted as characteristic more of one anemia
than the other, but these assertions have uniformly been found to be
without merit.

For example,

it has been the "clinical

many hematologists that extreme macrocytosis
deficiency.^

impression" of

is seen principally in Bi2

McPhedran et a 1. 1 s recent study of 100 consecutive

patients with macrocytosis demonstrates the fallacious nature of this
belief;^® the highest MCV's were actually observed
with folate deficiency but normal

in cirrhotic patients

plasma B^ levels.

Therapeutic Trials

After Wills'

initial

studies

it was felt by some that the

hematinic in "marmite" was the same active principie, present
liver, which was effective

in pernicious anemia.

in fresh

Even after this was

shown not to be the case,^ many physicians persisted

in the treatment

of Addisonian anemia with folate, a practice which led to the demonstration
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by Vilter et_ aj_.

in 1950 that while folate could regularly induce

hematologic remissions

in pernicious anemia,

or even precipitate neuropathy.^^

it seemed to exacerbate

Vilter et al.

exerted a "mass action" effect on hematopoe i s i s

proposed that folate
in

deficiency,

forcing some biosynthetic reactions

in the nuc1eoprotein pathway which

were also dependent on cobalamins.

He suggested that this effect

could be deleterious
tissues for

in terms of the separate needs of non-hematologic

These studies led eventually to the formulation of a

concept distinguishing the physiologic from the pharmacologic effects
of folate.

In I960 Marshall

and Jandl

published their studies

demonstrating the utility of this concept.^

Patients classified by

other criteria as folate-deficient were found to respond with brisk
reticu1ocytoses to daily parenteral
No additional

administration of 400 meg of PGA.

reticu1ocytosis was observed when the dose was

to 15 mg daily.

Just the opposite was found

increased

in patients with

Addisonian anemia; no responses occurred with the smaller dose, but all
patients had maximal
folic acid.

hematologic responses to 15 mg of parenteral

Great enthusiasm was expressed for the clinical

diagnostic tool, but this approach has not received general
for several

practical

reasons.

The financial

trial

as a

acceptance

cost of the twenty-odd

days of observation required for an adequate trial

is often prohibitive.

Complications such as congestive heart failure precipitated by prolonged
profound anemia may render such an extended undertaking unjustifiable.
oO

Deficiency not yet manifested by anemia'11
approach.

might be undetectable by this

Finally, deficiencies of the two vitamins may coexist, which

further complicates the design and

interpretation of such studies.
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Assay of Folate Activity in Human Tissues

Greater success has been experienced with attempts to assess
folate status by measurement of the quantity of vitamin present
fluids.

Although early reports predicted the futility of this

a bioassay of "folic acid activity"
of remarkable clinical

serum of fasting normal
ciated factors;

in 1959-3^

Subsequently,

inability to detect folates

in the

subjects was the consequence of two unappre¬

i.e., the specific auxotrophisms of various assay

organisms^ and the nature of the folate coenzymes present
serum.3&

33

approach,

in human serum which appeared to be

utility was published

it was shown that early workers'

in body

Almost all

in human

serum folate was found to be N^-CH^-FH^, which

would support the growth of Lactobacillus casei but not Streptococcus
faeca1is , which had been used as the assay organism by most earlier
investigators.
Although minor modifications of the original assay technique
have been

introduced, the estimation of serum folate by bioassay has

become a valued clinical
In practical

tool.

It

is not without

its shortcomings.

terms the assay is tedious, time-consuming, and therefore

not generally available.

It

is subject to the same types of distortions

as are other bioassays; e.g., artifactual 1y low values resulting from
the presence of antibiotics or antimetabolites
clinical
normal

import,

diets.

7 and 2b ng/ml

in the serum.

Of greater

it is perhaps too sensitive to the fluctuations of

While Herbert was able to define a "normal

range" between

of serum folic acid activity, the statistical

basis of

/

18
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this definition was never stated, and he was forced to include groups
classed "suggestive of deficiency" and "indeterminate" to describe
subjects with values between 3-0 and
experimental

6.9

ng/ml.37

His own study of

folate deficiency demonstrated that only three weeks of

negative folate balance sufficed to produce a fall
less than 3.0 ng/ml

(indicative of "unequivocal

in serum folate to

deficiency").

A full

18 weeks elapsed before macrocytosis appeared, and only after 19 weeks
of essentially no folate intake did megaloblastic anemia develop.^8
In summarizing the experience of many observers, Chanarin noted that
approximately one-third of all
below the normal

range.38

hospitalized patients had serum folates

Finally,

normal values might occur in

it is possible that deceptively

individuals depleted of folate stores,

if the specimen assayed were obtained within six hours of a folate-rich
meal.39

For these reasons, there

apart from the technical
the serum test renders
relegates

is now a general

consensus that quite

difficulties of the assay, the sensitivity of

it useless as a screening procedure and

it to a confirmatory role

in suspected folate deficiency.

Since the information actually sought

in measurement of folate

levels

is an estimation of the status of intrace 11u1 ar active coenzyme

pools,

it might be predicted that direct tissue assays might be of

greater diagnostic value.
deprivation study,

This

is also suggested by Herbert's folate

in which erythrocyte folates were measured by bio-

oO

assay. °

Abnormally low values of this parameter did not appear until

17 weeks, much closer temporally to the appearance of clinical

deficiency.

In an attempt to correlate the morphologic manifestations of deficiency
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with biochemical

-

changes, Cooper and Lowenstein studied 63 patients

who had serum B^? serum folate, and red cell

folate determinations

made within 48 hours of bone marrow aspiration.^®

None of these

patients was receiving antimetabolites or antibiotics, and none was
presumed to have pernicious anemia.
were found

in 48 of the 63-

marrow changes.

Low serum folates

(<.4.1

ng/ml)

Only 21 of these 48 had any megaloblastic

Every megaloblastic marrow was accompanied by either a

depressed RBC folate

(17 patients) or low serum B1 2

(4 patients).

In

contrast, among the 27 patients with normoblastic maturation but
depressed serum folates, RBC folates were normal

in all except 4 or 5.

The authors concluded that the serum folate was the more valuable
screening test since it identified all megaloblastic patients.
alternative reading of these results
cell

folate and serum B^ will

An

is that measurement of both red

identify all megaloblastic patients

with far fewer "false positive" tests.

This is the more widely accepted

position, and the erythrocyte folate determination has gradually replaced
the serum folate estimation as the most widely used clinical

indicator

of tissue folate depletion.^
Although the red cell
valuable clinical

folate has been shown to be an extremely

tool, some theoretical

arguments can be raised

against

its use as an index of "tissue" folate stores.

assayed

is highly atypical; the very biosynthetic processes believed to

be deranged
Moreover,
pools.

in mega 1ob1astosis are inoperative

red cell

The tissue being

in the mature erythrocyte.

folate is not freely exchangeable with other tissue

Intraerythrocytic folate seems to be primarily in the form of

20
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high pol ygl utamates^
erythrocyte,

trapped

i ntracel 1 ul arl y for the life of the

and the cell's entire folate pool

it reaches maturity.^

Of more practical

be relied on to assess folate status
This

intriguing problem will
Minimal

Total

data

-

is acquired before

significance, the test cannot

in the presence of B12 deficiency.

be discussed further (vide

infra p. 45).

is available on the folate content of liver.

hepatic folate content seems to correlate poorly with the fasting

serum folate.^

The "normal

available suggest that

range"

is unknown, but what values are

liver folate is depleted

deficiency severe enough to produce anemia.
human

def iciency

but reduced

in

folate

It is perhaps normal

in

~depl eted rats.The

2

necessity of resorting to invasive techniques
type of information obviously diminishes

in nutritional

in the acquisition of this

its clinical usefulness.

Recently a non-competitive binding radioassay of folate suf¬
ficiently sensitive to measure accurately the range of concentrations
present

in human serum has been published.

48

Although the peculiarities

of bioassay are obviated by this approach, the objections to any measure¬
ment of serum folates as the index of body stores remain pertinent.
Application of the test to measurement of red cell

folate would seem to

be an appropriate modification.

Folate Loading Studies

While intravenously administered folic acid has been found to
disappear more rapidly from plasma in folate deficient subjects than

21
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in normal
retarded
spread

-

controls, clearance of some forms of folate may actually be
in

deficient

37

patients.

investigative application

(vide

complex to be of routine assistance

Such studies have had wide¬
infra p.

30), but they are too

in the differential diagnosis of

megaloblastic anemia.

Studies of Metabolic Derangements Produced by Folate Deficiency

As might be apparent from inspection of Figure 3,

the

metabolic disturbances to be anticipated as a consequence of the
depletion of folate coenzymes are numerous.

Many attempts to assess

effective folate stores have been based upon searches for abnormal
accumulation or depletion of metabolites
single-carbon transfers.

rats.^9

in

In 1953 a metabolite of histidine was found

increased amounts

in the urine of folate deficient

Subsequently, this substance was

glutamate

(FIGIu).

and FH^ as acceptor,

identified as formimino-

In the presence of a formiminotransferase enzyme
free L-glutamate was

liberated with the formimino

group passing into the "single-carbon pool".
catabolism of histidine was
the urine.

in folate-dependent

Perhaps the most widely employed of these is

the so-called FIGIu test.
to be present

involved

In the absence of folate,

interrupted at FIGIu, which spilled

In 1959 Broquist and Luhby found

in the urine of folate deficient patients.50

into

increased amounts of FIGIu
Although no actual data

were given, he claimed that the finding was specific for folate
deficiency;

i.e., normal or absent excretion was supposedly found in
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persons with pernicious anemia.

This test has been widely adopted

clinically in slightly modified form.

Most

investigators have admin¬

istered two to twenty gram doses of histidine orally, then measured
urine FIGIu.

Excellent concordance has been found between the results
Cl

of this assay and the red cell

folate in individual

patients.

Zl 1

’

As experience has accumulated, the test has been shown to be less
specific than originally hoped.

Abnormally elevated urine FIGIu's

pernicious anemia have been a frequent finding, even
a low serum or red cell

in

in the absence of

folate.Increased amounts of the com¬

pound also appear in the urine of patients with liver disease,
Hodgkin's disease, and myelosclerosis,
deficiency;

in the absence of either vitamin

false negatives are often observed

in the megaloblastic
C 1

anemia of pregnancy or in the p'eserice of severe protein deficiency.
The FIGIu test

is no longer performed routinely in most institutions.

Employing far more "physiologic" doses
1^C-2(imidazole)-L-histidine,

injected

(0.5 mg) of

intravenously,

Fish and co¬

workers were able to differentiate folate deficient from B]2 deficient
subjects by monitoring
Cumulative

1A

1A

CO2 expired over a two hour period.

52

CO2 excretion was reduced by an order of magnitude, and

the time to maximal

minute excretion

(Tmax) was delayed severalfold

among folate deficient patients as compared with controls or B12
deficient subjects.

The latter two groups were

indistinguishable.

Although these data are impressive, the number of patients studied is
small

and the test is not widely available.

to demonstrate a similar defect

Moreover, a recent attempt

in vitro has been unsuccessful.

-23

Erythrocytes of rats which had been rendered folate deficient or
deficient by means of dietary restriction were
amounts of ^C-2 (i mi dazol e)-L-h i st i d i ne.

incubated with minute

No differences were observed

in either Tmax or cumulative evolution of
deficient groups and control

animals.^3

between the two
The interpretation of this

finding in a highly specialized system such as the red cell

is of

course problematic.
Since the biosynthesis of the purine nucleus

is completed

by transformy1 ation from a folate coenzyme to 5~amino-4-imidazole
carboxamide

(AICAR), yielding

inosine monophosphate

accumulations of AICAR have been sought as an
folate depletion.

(IMP), abnormal

index of significant

Surprisingly, the first such effort

increased urinary excretion of AICAR was not observed
deficient patients but was universally detected
anemia.

indicated that
in folate

in untreated pernicious

Another report soon followed, however,

in which this dis¬

criminatory capacity was refuted,^5 and this test has fallen

into disuse.

Recently a study purporting to demonstrate a more generalized
derangement of single-carbon metabolism specific for folate deficiency
has appeared.
deficient

in

Tran et_ aj_.

incubated erythrocytes of rats made

or folate with ^C-formate and measured the ^CC^

evolved over three hours.

B1 2 deficient animals yielded results

indistinguishable from controls, but ^CC^ production by red cells of
folate deficient rats was markedly reduced.53
virtually uninterpretab1e for several

reasons.

The study is unfortunately
No parameters were re¬

ported which assured that the animals were indeed depleted of one or
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the other vitamin;

in fact, the "folate deficient" group may have been

choline deficient.

In addition,

seems to have been poor.

reproducibility between experiments

Final ly, an earl ier j_r^ v i vo study in rats

had demonstrated abnormalities of endogenous and exogenous formate
metabolism which were caused by either vitamin deficiency.5^
The interconversion of glycine and serine

is yet another

folate-dependent b i ot rans format i on , 57 N^N ^-CH2-FH 4 being the required
cofactor.

In rats,

folate deficiency was shown to abolish the

incorporation of ^C-formic acid
hepatic and visceral

into the £ -carbon of serine of

protein,58 but no abnormality of glycine-serine

interconversion was observed when this was first studied in human folate
deficiency.59»50

The techniques employed were

insensitive (measurement

of plasma serine before and after 25 gram glycine infusion)
patients studied less than
blastic marrows; all
1970,

ideal

(all

had tropical

and the

sprue and megalo¬

responded to subsequent folate treatment).

a preliminary report appeared

in which defective glycine-serine

interconversion, assessed by ^C-formate incorporation into the
of serine of lymphocytes
deficiency.^

In

-carbon

in vitro, was found in 8 patients with folate

A "relative" defect was also observed among 12 patients

characterized only as having gastrointestinal malabsorption and normal
indices of folate stores.

In the folate deficient group the defect was

not entirely abolished even after four to six weeks of daily oral
therapy.

PGA

Unfortunately, no patients with B1 2 deficiency were reported,
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which renders the specificity of the assay problematic.3
the experimental work to be presented here will

Some of

be directed towards

questions raised by this report; e.g., whether the results can be
duplicated, what specificity can be claimed for the assay if it
indeed a reliable

is

index of folate deficiency, and what significance can

be ascribed to the presence or absence of such abnormalities

in vitamin

deficiency.

aWhile the present studies were in progress, a more detailed report of
this work appeared.The authors stated that they had observed im¬
paired serine formation in lymphocytes from pernicious anemia patients,
but no data were given.
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THE BIOCHEMICAL BASIS OF MEGALOBLASTOSIS

Many of the cytomorphologic features of the megaloblastic
anemias suggested a profound derangement of metabolic events occurring
within the cell

nucleus, but the nature of these changes could not have

been appreciated prior to the elaboration of our present concepts of
the structure and function of the genetic apparatus.
the several

roles of folates

Elucidation of

in the synthesis of both purines and

pyrimidines rendered attractive the concept of impaired nucleic acid
biosynthesis as the central

lesion in megaloblastic erythropoeisis.

The 1ong-recognized "maturation arrest" and "nuc1eocytop 1asmic
dyssynchrony" so characteristic of the megaloblastic marrow were
interpreted as morphologic expressions of this biochemical abnormality.
This thesis was supported by the observations that uracil or thymine
given orally were capable of inducing hematologic remissions.^1
Rundles and Brewer reported that oral
anemia resulted

in a limited remission in 1958.

specific information to reveal
however;

orotic acid therapy of pernicious

hemoglobinization

Morphology had more

about underlying biochemical mechanisms,

(protein synthesis)

and hence messenger RNA

synthesis seemed to proceed relatively unimpaired
In retrospect, Thorell's earlier demonstration
of normal

in the megaloblast.

in 19^7 of the presence

to increased amounts of RNA in mega 1ob1astsD

of this concept.
tion that while

was supportive

In 1963, Williams and coworkers^ added the informa¬
incorporation of purines and pyrimidines

pernicious anemia megaloblasts was normal, there was an

into RNA of
impaired
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incorporation of adenine, guanine, and cytosine into DNA.
found to be ameliorated by addition of exogenous

This was

to the cultures.

Role of Ribonucleotide Reductase

In the light of the above evidence, attention was quite
naturally directed towards the characteristics distinguishing the two
polynucleotides from one another;
and the replacement of uracil
advanced by Beck^

in

1961,

i.e.,

the presence of deoxyribose

by thymine in DNA.

An early hypothesis

and restated more emphatically in

focused on the B12~dependent ribonucleotide reductase present
Lactobacillus

leichmanii.

abnorma1ities produced

growth on a B^'depleted medium (long,
divide, with impaired DNA synthesis

in this organism by

filamentous organisms unable to

in the face of normal

RNA and

and the morphologic aberrations of mega 1ob1asts.

He suggested that the pathogenetic lesion
be an

in

Beck developed an analogy between the

morphologic and biochemical

protein synthesis)

1965,^

in pernicious anemia might

inability to reduce ribonucleotides to their deoxy- analogues.

One obvious conceptual

flaw in this hypothesis was that

account for the intimate nutritional

relationships between folates and

B-|2^ and for their interdependent roles
amelioration of megaloblastosis.66,67
evidence accumulated,

it failed to

in the development and

Furthermore, as experimental

it became clear that the reductase of mammals

differed markedly from that of j^.
requirements and control

1 e i chman i i

mechanisms,

in terms of substrate

resembling far more the B^"

independent reductase isolated from E_. col i

o
.0

ro

’

Nevertheless, Beck
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continued to advocate his position, citing unpublished studies from
his own

laboratories supposedly demonstrating the B^2~dependence of

marrow reductase.^

In 1969,

Fujioka and Silber reported their

inability to stimulate marrow reductase with exogenous B^-^
Sufficient purification was not possible, however, to exclude the
presence of enzyme-bound cobalamin

in their preparations.

feature reminiscent of the E_. col i

reductase,

was also found by Fujioka and Silber.

An additional

inhibition by hydroxyurea,

Beck's studies apparently remain

unpublished, and his hypothesis appears untenable at the present time.
The properties of the different ribonucleotide reductases are summarized
o

in Table 2, modified from Silber and Moldow.

The Hethylfolate Trap Hypothesis

Following the elucidation of the role of vitamin B12

'n the

methylation of homocysteine, Noronha and Silverman noted that methionine
administered to B^2“dep1eted rats could eliminate their excessive FIGIu
excretion, and also alter the distribution of folate coenzymes
from predominantly N^-CH-^-FH^ to N^- and N^-CHO-FH^.

in liver

They concluded

that the folates had been trapped, by B^ deficiency, as N^-CH^-FHZj,
and that administered methionine had
for the folate methyl

in some way acted as an acceptor

group, thus circumventing the trap and regenerating

free FH^, which became an effective receptor for the formimino group of
FIGIu.^

Herbert and Zalusky applied this concept to the clinical

setting.

They noted that 17 of 100 consecutive patients with pernicious
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anemia presented with serum folate levels elevated to a degree seen
otherwise only in subjects

ingesting large amounts of folic acid.

They proposed that this may have represented a "piling up" of
methylfolate

in the serum,^ since most serum folate was N^-CH^-FH/^.

To test this hypothesis, they infused
venously

into normal control

15 mcg/kg of folic acid

intra¬

subjects and patients with folate, B12»

of combined folate and Bj2 deficiencies.
were cleared rapidly from the serum of all

Folates other than N^-CH^-FH^
deficient subjects, but

in

the patients with untreated pernicious anemia N^-CH^-FH^ tended to be
retained for several
with vitamin B^-

hours.

This plateau was abolished after treatment

Moreover, the initiation of B -j

pernicious anemia regularly induced a fall

2

treatment

in plasma folate.

in
On the

basis of this evidence, they concluded that the underlying defect

in

mega 1ob1astosis was a generalized slowing of folate-mediated single¬
carbon transfers, and that B ^
directly through its

2

deficiency could bring this about

in¬

role in the regeneration of FH^ from N5-CH^-FH^.^

They also suggested a re-interpretation of the findings of Noronha and
Silverman more in keeping with the known roles of the
metabolites;

i.e., that methionine abolished FIGIu excretion by acting

as an end-product
N^-CH^-FH^.

individual

inhibitor of the enzymes leading to the formation of

Herbert and Zalusky's "methylfolate trap hypothesis" has

become the most widely accepted formulation attempting to account for
the obviously intimate interrelationship of vitamin B^ and folic acid.
Several
followed.

studies tending to support this proposal shortly

In the most comprehensive of these, Waters and Moll in found

the mean serum folate of 100 consecutive patients with untreated
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pernicious anemia to be significantly higher than that of healty controls.
Perhaps more revealing, the highest serum folates were found among
patients with the lowest serum Bi2
anemia was minimal.

levels, provided that the degree of

The authors suggested that the lower serum folate

seen inconsistently in more anemic subjects were a consequence of anorexia
leading to true nutritional

folate depletion

serum folate apparently precipitated by

in these patients.
treatment was again

A

fall

in

observed.72

That B^2 deficiency impairs utilization of plasma methylfolate is by no means established with certainty.

The results of some

clearance studies have been distinctly at variance with Herbert and
Zalusky's findings.

Chanarin and Perry were unable to distinguish the

clearance of infused synthetic N^-CH^-FH^ from the plasma of pernicious
anemia patients as compared to control
accelerated

in folate-deficient

subjects; clearance was

patients.73

All

been criticized as being highly nonphysiologic.
produced peak serum folate levels of greater than
subjects;
50 ng/ml.

in Chanarin's study the maximal
The only parameter assessed

such studies have
Herbert's
300

ng/ml

infusions
in some

concentrations were near

in many patients was disappearance

from plasma, which may be a very poor index of changes occurring in
intracellular pools.

Recently a clearance study

factors were better controlled has appeared.7^>75
pernicious anemia were given

in which some of these
ywo patients with

infusions of 5 mcg/kg of N^-^ ^CH-^-FH^-^H

before treatment and again after establishment of remission with B12
therapy.

Three others were given only 0.05 mcg/kg of N^-CH-^-FH/j-^H .

In the first group, serum folates were raised to greater than 50 ng/ml
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five minutes after infusion.

No rise in the serum folate was produced

by the 100-fold smaller dose used
given the much

in the second group.

larger dose, there was

In the group

insignificant delay of plasma

clearance of N^-CH-^-FH^, as compared with post-treatment clearance rates.
In the three patients to whom only tracer amounts were administered,
clearance of methylfolate was definitely retarded, and was significantly
accelerated by 1000 meg of CN-B]2

injected 24 hours after the infusion.

No such enhancement of clearance by an
the

injection of Bi2 was seen when

infusions were repeated with the patients

in remission.

Urinary

excretion of the infused materials was found to be two- to four-fold
greater before treatment.

After therapy, greater utilization presumably

accounted for less appearing in the urine.

Moreover, while less than

ten per cent of the lower dose of infused folate-^H appeared
urine within 6 hours,
the 100-fold

forty-four per cent of the

larger dose was excreted

in the

administered

in this same time period.

in
In

summary, the most "physiologic" studies reported to date strongly sug¬
gest that

deficiency does result

in reduced transfer of N^-CH^-FH^

from the plasma to body tissues.
Based upon the assumption that

increased endogenous methyl¬

folate pools would dilute

production from exogenous N^-CH^-FH^,

it has been suggested that such

increased pools were not present in

B^ deficient

76

rats.

Since the pathways by which the methyl

methionine (and hence N^-CH^-FH^)
actual

group of

is converted to CO2 are unknown, the

meaning of this finding is unclear and may have little to do

with methylfolate pool

sizes.
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The methyl folate trap hypothesis requires that, once formed,
N^-CH^-FH/j can be metabolized only in the presence of the cobalamindependent methyl transferase.

No role other than the methylation of

homocysteine has been found for N^-CH^-FHAj in man.
Foster,a coba1 amin-independent transferase

If, as suggested by

is also present, the trap

would be ineffective, but there are no studies yet available which
support Foster's contention.

It would be anticipated that decreased

activity of the methyl transferase would result
methionine synthesis.

This

in decreased de novo

is supported by the finding of low serum

methionine levels

in pernicious anemia which return to normal

following

B-\2 treatment.77

Accumulation of homocysteine would be expected also,

and has been observed.78
Methylfolate might also be released from the trap by re¬
oxidation to its precursor, N^N ^ ^-CH2-FH^.

The enzyme involved,

n5n10-methy1enetetrahydrofolate reductase, has been studied extensively
from both mammalian liver and E_. col i .

Although usually assayed

in the

"reverse" direction, by trapping of formaldehyde released nonenzymatica11y
from N^N^-CH2_FH^79 as the dimedone adduct,
FH k

<-

->

HCHO

the presence of an artificial

FADH'

FAD

NAD

NADH, H+

electron acceptor, menadione,

to drive the reaction in this direction.
assayed

l5-CHo-FH,

n5n10-ch2-fhZ|

The enzyme from E_.

is necessary
col i ,

in this manner, was found to have a Keq of 2400 favoring
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reduction of methylenefolate.

Assayed

in the "forward" direction by

monitoring FADH2 oxidation, the Keq was calculated at 3400.
of the methyl

group hydrogens becomes

Only one

labelled when N^N^FH^ is

reduced enzymatically in tritiated water, also suggesting functional
irreversibility.^

Although no thermodynamic data are available on

the mammalian enzyme, they at

least share similar pH optima.

A some¬

what capricious attempt to circumvent the "trap" clinically was
reported by Herbert et_ aj_. ,^1 who injected menadione, both intra¬
venously and directly into the marrow.

No reticu1ocytosis, fall

in

serum folate, or reversion of the marrow morphology towards the normo¬
blastic state was observed.

The authors admit that the study is

uninterpretable.
The regulatory role of methionine in the biosynthesis of
methylfolate has also received considerable attention.
Sullivan demonstrated that

Herbert and

in patients with megaloblastic anemia

methionine suppressed FIGIu excretion.

They suggested that

of methylenefolate reductase could be responsib1e.^2

inhibition

Dietary methionine

supplementation did reduce the activity of the reductase from rat liver,
but only by
methionine

25-50%.^

|n E_. col i ,

it was found that the presence of

in the growth medium resulted

reductase in homogenates.

in low activities of the

The mechanism was not allosteric modification

of the apoenzyme, since addition of methionine directly to homogenates
did not reduce activity.^

In summary, these studies,

if applicable to

the human reductase system, would suggest that FHZ| cannot be re¬
generated by oxidation, and that methionine may exert

its effect on
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FIGIu excretion by repressing synthesis of the reductase.

Such a

sparing effect of methionine on folate trapping is at odds with Rundle
and Brewer's single case report of a patient with pernicious anemia in
whom methionine feeding seemed to accelerate the development of
rel apse .

^
It has also been suggested that the effect of methionine

reducing FIGIu excretion

in

is not a manifestation of liberation of

"trapped" folates, but simply a result of competition for a common
membrane transport mechanism for methionine and histidine,
delivery of the latter to catabolic pathways.^2

reducing

This seems unlikely

in view of the observation that dietary methionine supplementation
permitted normal

^CC>2 excretion from

tions of l^C-2 (i mi dazol e)-h i st i d i ne. 76
histidine catabolism was observed

deficient rats given

injec¬

No such facilitation of

in a single patient with untreated

pernicious anemia,^ but ^CC>2 excretion was normal

in this subject

prior to methionine supplementation.
The trap hypothesis obviously requires that N^-CH^-FH^ be
totally ineffective in

inducing remission in B^ deficiency.

been impossible to obtain
test this directly.

It has

large enough quantities of methylfolate to

The ability of oral

folic acid to elicit maximal

hematologic responses raises questions about the metabolism involved in
absorption of folates.

Some studies have

indicated that oral

totally reduced and methylated by the intestinal
studies that some oral

PGA is

mucosa,^ other

PGA is absorbed unchanged>86

When both

portal and systemic folates were analyzed after administration of 500 meg

36-

-

of L-PGA, apparently the compound was absorbed unchanged,
extensive hepatic reduction and methylation
methy1folate).^

followed by

(or displacement of liver

While much remains unknown about the absorption of

folic acid, present evidence suggests that at

least some does enter

the systemic circulation in reduced forms other than N^-CH^-FH^.
This "untrapped" fraction might be sufficient to support hematopoeisis
in pernicious anemia patients treated with oral
Portal

PGA.

venous folates have also been characterized following

ingestion of folinic acid

(N^-CHO-FH/j) .

This compound appeared to have

been almost completely reduced to N^-Ch^-FHZf by the intestinal
On the basis of this

information,

mucosa. ^

it was assumed that “for tissues

other than the intestine, the feeding of folinic acid is equivalent to
the feeding of 5~methy1tetrahydrofolate itself".^

Accordingly, a

patient with untreated pernicious anemia was given 6 mg of folinic acid
daily for 6 days.

The brisk reticu1ocytosis and reversion of the

marrow to normoblastic maturation which followed were considered to have
disproved the trap hypothesis.^9
against this conclusion.

Several

arguments can be raised

In the experiments upon which this study was

based,^ approximately 15% (150 meg) of the active stereoisomer of each
2 mg dose was absorbed

into the systemic circulation unchanged.

While

the authors felt that the 450 meg/day of "untrapped" coenzymatic folate
thus

introduced would have been

observed, this

is

insufficient to produce the changes

inconsistent with abundant evidence that the daily

folate requirement of man

is only about 50 mcg.^O

Moreover,

it

is well

established that 400 meg/day of PGA is sufficient to produce a hema-
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tologic response in folate deficiency.32

Finally, a recent study

demonstrated that the 1 -C unit of orally administered N^-^CHO-FH^-^H
is rapidly cleaved from its carrier, not simply reduced to methylfolate. 91

This

indicates that feeding of N^-CHO-FH^

is quite different

from supplying pure methylfolate.
An observation which may suggest a role for cobalamins
hematopoeisis,

independent of effects on folate metabolism,

seems to promote normal marrow maturation even
folate.

is that B12

in the "absence" of

Three folate deficient patients with megaloblastic anemias

and normal
maximal

in

serum

levels who responded to B ^

2

therapy with near-

hematologic responses have been reported.^7

unable to elicit such responses,92 and
effect of B^ was to promote optimal

Others have been

it can be postulated that the

redistribution of remaining

folate coenzymes.^7

Studies of Megaloblast Proliferation

The methyl
only a generalized

in vitro

trap hypothesis as originally conceived proposed

impairment of nucleic acid biosynthesis brought

about by interference with folate-dependent single-carbon transfer re¬
actions.

For reasons discussed earlier, attention over the past decade

has been focused on biochemical events peculiar to DNA synthesis.

In

1964, Schmid e_t_ a_l_. demonstrated that 54% of pol ych romatoph i 1 i c megaloblasts, as opposed to only
still

23%

of polychromatophi1ic normoblasts, were

actively synthesizing DNA.

They suggested that megaloblastic
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maturation was characterized by an
(non-differentiating)

mitoses

marrow cy tok i net i cs published

-

increased percentage of "homoplastic"

in the marrow.93
in 19&7 and

the aberrations of DNA biosynthesis

Elaborate studies of

1968 better character ized

in pernicious anemia mega 1ob1 asts.

A greater percentage of megaloblastic than normoblastic cells were found
to be

in the G2 phase of the cell cycle, as demonstrated by their

tetraploid

(^tC)

DNA content and failure to take up 3h -1 h y m i d i ne .

While

polychromatophi1ic normoblasts could easily be assigned to either the
G1 ,S, or G2 phase of the cell

cycle, megaloblastic marrows contained

many polychromatophi1ic cells which were not engaged

in DNA synthesis

but yet had DNA contents scattered between the 2C and 4C amounts.
These data were considered
mega 1ob1asts.

The

indicative of abortive DNA replication

increased frequency of cells

thought to suggest an

in the G2 phase was

inability of megaloblasts to enter mitosis fol¬

lowing completion of DNA replicat ion.9^>95
confirmed

in

These observations were

independently by Yoshida et_ aj_. ,^6 who found that the cell

cycle abnormalities were eliminated within 2k hours of starting treat¬
ment with 1000 meg C N-B ^ 2•

Yoshida's study also indicated that RNA and

protein synthesis progressed at accelerated rates

in megaloblasts from

untreated patients.
In 1968, a biochemical
with the methyl

lesion in DNA synthesis consistent

trap hypothesis was demonstrated

megaloblasts by Metz and coworkers.97
(dll)

had earlier been shown to be

in cultures of marrow

The methylation of deoxyuridine

impaired

in Bi2_def i cient animals,

and some workers had suggested that CH3-B12 functioned coenzymatica11y
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in this reaction.

Although others were unable to demonstrate such a
r

requirement for
estab 1 i shed .98

in

the role of fPN
Metz £t_ a_l_.

-CH2-FHZ| as C-l donor was

incubated marrow cells

labelled dll and then added 3hl-thymidine (3H-dTR)
In normal

-

marrows,

in vitro with un¬

to the cultures.

the dU preincubation was able to suppress

incorpora¬

tion of subsequently added 3H-dTR into DNA to less than 10% of control
(non-dU-preincubated)

values.

This effect was considered to indicate

methylation of the dU and subsequent competition with the added ^q-dTR.
In marrows from B1 2 -deficient patients, dU preincubation could not
suppress 3n-dTR incorporation,
dU.

Addition of 1 meg of

indicating a "block"

in methylation of

to the culture medium partially re¬

established the dU suppression, but 50 meg of PGA completely restored
it.

Even more striking was the finding that 50 meg of N^-cH3-FH4 was

unable to restore dU suppression
did so nearly as well
patient.

in B^2~deficient marrows, while it

as PGA in the marrow of a folate deficient

That the role of B^ was an

indirect one was demonstrated

by the ability of methotrexate to cancel
findings offered
hypothesis.

its effect completely.

These

impressive support for the methylfolate trap

It could now be postulated that the principal effect of

the trapping of folates as N^-CH^-FH^ was the depletion of its

im¬

mediate precursor, N^N^O-Cf^-FH^, the substrate for the methylation of
dU.97

The inability of pernicious anemia megaloblasts to incorporate

dU into DNA also argued against Beck's localization of the lesion at
ribonucleotide reduction.
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Metz's experiments were extended to study the effects of
methionine and homocysteine on the defective dU suppression of
megaloblastic marrows.99

As discussed earlier, methionine had been

shown to reduce FIGlu excretion and somehow to release "trapped"
folates

in Bi2 deficiency.

Surprisingly, methionine was found to block

the corrective effect of B12
product

in pernicious anemia marrows. 99

End-

inhibition of homocysteine transmethylase, as suggested

rat liver,^ was

in

invoked as a possible mechanism of this effect.

Homocysteine partially restored dU suppression of ^H-dTR incorporation
in pernicious anemia megaloblasts
of a B12 antagonist.

Several

considered by the authors,

in the absence of

or the presence

interpretations of these findings were

including the presence of a B^2“>ndependent

transmethy1ase which could regenerate FH^.
could have accepted some of the methyl

Alternatively, homocysteine

groups of N^-CH^-FH^ nonenzymatic-

ally by a mass action effect because of the large quantities of the
amino acid present;

1 mg of homocysteine was added to the cultures,

while only 50 meg quantities of folate coenzymes were sufficient to
restore dU suppression.

An alternative interpretation of the methionine

effect, not suggested by the authors, would require that methionine
suppressed not only N^N^0-CH2-FH^ reductase, but also pathways leading
to the synthesis of methylenefolate.
able pool of free FH^

If this were the case, the avail¬

for histidine catabolism would be increased by

methionine, thus enhancing FIGlu breakdown;
then lead to impaired dU methylation.
hypothesis are available, and

lack of l\|5|\|^(-)-CH2-FHi( would

No data in support of this

its plausibility

is questionable in view
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of the presence of a functioning non-enzymatic pathway in vivo for the
production of N^N

FH^ from FH^ and forma 1 dehyde . 79

On the basis of the dU suppression studies, the cytogenetic
abnorma1ities observed in megaloblasts have been
result of thymidine deficiency,
DMA helix.

No differences

to megaloblastic marrow cell

The Role of Cobalamins

interpreted as the

leading to single-strand breaks

in base composition of normal

in the

as opposed

DNA have been demonstrated, however.

101

in Pernicious Anemia Neuropathy

An attractive feature of the methylfolate trap hypothesis

is

that it seeks to explain the hematologic effects of B-]2 if terms of a
folate-dependent action, and the neurologic effects of Bj2
a folate-independent function.
activity of methy1ma1ony1

It has been suggested that reduced

CoA mutase,

man to require a B^ cofactor, could
neuropathy of pernicious anemia.

the only other enzyme known in
in some way produce the sensory

Recently some experimental

for this speculation has been developed.

Sural

from pernicious anemia patients and control
with i-propionate, both

label

and C17 saturated acids, whereas
was of

and

acids. ^

accumulated

in the medium.

subjects, when incubated
into fatty acids, but

appeared extensively in anteiso-Ci5

in control

|n rat glial

in B^ deficient medium elaborated

support

nerve biopsy slices

incorporated the label

in the B^ deficient slices,

if terms of

and

subjects the labelling
cell

cultures, cells grown
acids, and propionate

These effects were reversible by Bi2
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supplementation .103

The

inference made from these findings

the abnormalities of fatty acid biosynthesis observed
result

-

is that

in vitro may

in vivo in deranged metabolism of myelin surrounding peripheral

nerves, and thus bring about subacute combined degeneration of the white
matter of the spinal

cord.

A tremendous amount of speculation

required to postulate a causal
observations and the clinical
to regard the association as

is

relationship between the biochemical
lesions.

At present,

it seems prudent

interesting but of undertermined

significance.

Implications of

That

Inborn Errors of Folate and

impaired nucleic acid biosynthesis

in megalob1astosis

is the primary lesion

is supported by the appearance of megaloblastic

anemia in orotic acidura, an
more blocks

Metabolism

inherited disorder characterized by one or

in the pyrimidine biosynthetic pathway.The particular

consequences of cobalamin-folate interdependence specified by the methyl
trap hypothesis are supported by two recently described inborn errors
of folate metabolism.
blastic anemia,
activity

Arakawa et_ aj_. studied an

infant with megalo¬

increased urinary FIGIu, and elevated serum L^.

(N^-ChU-FH^) .

case i

They suggested that a deficiency of

N^-CH^-FH^-homocysteine transmethy1ase was responsible for the clinical
findings.
control

Activity of the enzyme from liver was

reduced to 30-50% of

values, but the range of activities of other enzymes measured

was so great among "controls" that the reduction of transmethy1ase
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activity in the patient could be considered to be within the limits
of reproducibility of the assays.

Also, no mention of homocystinuria,

a possible consequence of such an enzymatic block, was made.
Methylenetetrahydrofolate reductase deficiency has been
reported

in two sibships.^^

This block would not be expected to pro¬

duce megaloblastic anemia and apparently did not.

Homocystinuria,

presumably consequent to N5-cH-FH4 deficiency, was present
patients.

in these

Surprisingly, neither serum nor tissue NS-CH^-FH^ levels

were reported.

Methyltransferase activities were normal.

Inherited disorders of Bj2"dependent metabolism have also
been described

in recent years. ^7

Several

children have now been

reported with metabolic ketoacidosis and methylmalonic acidemia
secondary to methylmalonyl-CoA mutase deficiency.

The methyl

trap

hypothesis would predict no impairment of hematopoeisis resulting from
such a block, and megaloblastic anemia has not been observed.

The

methylmalonic acidemia phenotype is now recognized to be genetically
heterogenious, some patients apparently having a mutant apoenzyme,
1 Q O

others being unable to accumulate the coenzyme dA- B12

int race 1lularly.luo

More profound genetic defects of cobalamin metabolism have also been
described.

An

infant reported by Levy et al.^ ^ died at 7i weeks of

age, ending a clinical

course characterized biochemically by persistent

hypomethioninemia, homocystinemia, and methylmalonic aciduria.
Megaloblastic changes were not observed

in marrow aspirates, but fre¬

quent transfusions were required to maintain the infant's hematocrit.
Tissue enzyme analyses revealed depressions of the B-j 2_dependent methyl-
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transferase and methylmalonyl“CoA mutase, which could be rerestored
towards normal

by high concentrations of the appropriate cofactors.^

The postulated enzymatic block in this child must be at a point common
to the biosynthesis of both cobalamin coenzymes;
the cell or reduction of the central

i.e., transport

into

cobalt atom,^7 or some subsequent

step required for formation of each coenzyme.

A biochemically

similar, though clinically less severe,

lesion has been observed

in

two siblings by Goodman et a 1 . . ^ ^ , 11 3

Both of these children had

methylmalonic aciduria and homocystinuria, but plasma methionine levels
were normal.

Neither had megaloblastic or macrocytic changes, and

on this basis Goodman raised arguments against the plausibility of the
methyl

trap hypothesis.

The diminution of methyltransferase activity

was asserted to be at least as great

in his patients as occurs

in

pernicious anemia, because of the magnitude of homocystine excretion
in the two conditions.
been measured in human

Methyl transferase activities have not actually
deficiency, but the reduced plasma methionine

levels usually found would suggest a more profound reduction of methyltransferase in untreated pernicious anemia.
mains unsettled.

The lack of mega 1ob1 astosis

At present, the issue re¬
in the infant dying with

a far greater reduction of methyl transferase activity is more difficult
to explain, but in the presence of such a profoundly disturbed bio¬
chemical

milieu, the marked erythroid hypoplasia observed might have

obscured any tendency to megaloblastic changes.
The possible role of the propionate

—

methylmalonate

—

succinate pathway in the pathogenesis of the neurologic manifestations

of pernicious anemia has been mentioned earlier.

Although clinical

signs of dorsal column dysfunction have not been reported

in either

methy1ma1ony1-CoA mutase deficiency or the "combined defect" syndromes,
mental

retardation and hypotonia1^ have been prominent features.

Autopsy has either not
diffuse and focal

included the neuropathology^5 or demonstrated

softening of cerebral white matter.There is no

justification at present for attributing the neurologic manifestations
of these syndromes to the abnormalities of fatty acid biosynthesis
observed

in vitro in

deficiency.

Other Postulated Roles for

'n the Development of Mega 1 ob 1 as tos I s

An unconfirmed report has appeared suggesting a role for
CH3-B^2

'n methylation of tRNA.^7

it was suggested that

in B^2

deficiency, non-methylated tRNA would accumulate which would be less
effective in amino acid transfer to ribosomes.
evidence presented earlier suggesting normal

The considerable

protein synthesis

in the

face of impaired nucleic acid metabolism renders this hypothesis
untenab1e.
A "geographic" rather than metabolic folate trap has been
postulated by Chanarin^^ to be the basis of megalobl astos i s
deficiency.

Erythrocyte folates are reduced

in B12

in approximately two-thirds

of B^ deficient patients and return to normal

following institution of

This may simply be a reflection of an older peripheral

therapy.

red cell

population rather than of impaired folate uptake by red cell
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1 1 O

precursors,110

The increased plasma/red cell

regularly observed

in Q]2

deficiency^

and

folate "gradient"

its rapid disappearance

following initiation of therapy suggest that folate uptake is indeed
impaired.
that

Analysis of this proposition

is complicated by the fact

intrace 11u1ar and extracellular folates are not freely exchangeable,

the former being largely polyglutamates.^

Kutzbach et al.

have

speculated that the impaired folate polyglutamate accumulation of rat
hepatocytes

in B1 2 deficiency may actually represent another mani¬

festation of methyl

trapping,

if, as

in E_. col ? ,

FHbut not N^-CH^-FH^

is the substrate for polyglutamate synthesis.^

(n the absence of any

understanding of the functions of polyglutamates

in mammalian systems,^0

it

is difficult to formulate any hypotheses explaining the known bio¬

chemical

consequences of cobalamin deficiency on the basis of poly¬

glutamate depletion.
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PURPOSES OF THE PRESENT STUDIES

Sufficiently sensitive assay techniques have not yet been
developed to render practicable the measurement of intracel1u1ar
folate coenzyme pools

in the clinical

setting.

Knowledge of the

metabolic roles of each of these compounds does make possible pre¬
diction of the consequences of depletion of individual
Since the methyl

coenzymes.

trap hypothesis requires a relative deficiency of

intracellular N^N^-CH2~FH^, estimations of the effective pool of this
form of folate would be illuminating.
requires this coenzyme,

As glycine-serine interconversion

it would be reasonable to expect this reaction

to be impaired consequent to B ^ 2 deficiency,
hypothesis were correct.
serine by peripheral

if the methyl

trap

Because impaired formate incorporation

into

lymphocytes has been reported to be a sensitive

indicator of folate deficiency,^

the intact leukocyte would seem to be

an

ideal

system in which to attempt confirmation of these expectations,

it

is also of importance to establish the specificity of the assay

it

is to be used clinically as a diagnostic tool.
Although not believed to be involved

if

in the development of

mega 1ob1 astosis , methylmalonyl-CoA mutase activity is known to be re¬
duced

in

deficiency'^ and may be a more specific indicator of the

deficiency state because of its

independence of folate metabolism.

Recent publications suggest that this
Low serum B^

independence may not be total.

levels which rose following initiation of specific

therapy have been found in 40-60% of patients with folate deficiency.121
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Intraerythrocytic cobalamin levels have been reported to be universally
low in folate deficiency. ^2
unexplained B^-folate

These observations suggest that an as yet

interaction may influence the cellular uptake

of both vitamins and raise the possibility that deficiency of either
will

bring about deficiency of the other.

The fact that methylmalonic

aciduria has been reported not to occur in pure folate
raises doubts about this hypothesis, but
sensitive assay would detect

it

deficiency^3

is possible that a more

impaired B-j2~dependent metabolism.

Impaired methylma1onate oxidation by peripheral

leukocyte extracts has

been reported to be a reliable test for Bj2 deficiency, even

in the

absence of significant methylmalonic aciduria,^ but the status of the
propionate pathway has not been evaluated
folate deficiency.

in uncomplicated nutritional
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MATERIALS AND METHODS

At the time of study, all

subjects but one were

on the wards of the Yale-New Haven Hospital.
healthy laboratory personnel.

Control

inpatients

subjects were

Prospective patients were selected by

means of erythrocyte folate bioassay using Lactobacillus casei
test organism;^
plasma vitamin

serum folate bioassay using the same organism; or
isotope dilution

^4

assay.

performed by the hospital's clinical

These tests are routinely

microscopy laboratory on all

patients found by Coulter Counter Model

S determination to have

erythrocyte MCV's greater than or equal

to 115 cubic microns.30

screening program proved to be an effective tool
suspected, and therefore untreated,
patients thus

as the

This

for detecting un¬

folate and B}2 deficiences.

identified were admitted to the Clinical

A few

Research Center

for study and to investigate the etiology of their deficiencies.
Patients receiving antimetabolite therapy were excluded from the study.
Oral

or written

informed consent was obtained from all

patients

being studied.

Preparation of Leukocyte Suspensions

Cells were prepared as described by Rosenberg et a 1..
Following an overnight fast,

15-30 ml

of venous blood was drawn into a

plastic syringe containing 90 units of sodium heparin
Co.).

2

The blood was then mixed with an equal

(Sigma Chemical

volume of \% (wt/vol)
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polyvinyl pyrrollidone
in 0.9 g/100 ml NaCl

(PVP-36O, Sigma Chemical

containing 45 mg/100 ml

Co., average MW 360,000)

D-glucose.

cytes were allowed to sediment for 45 minutes at 4°C at
15 minutes.

The erythro¬
140 x g for

The supernatants were decanted and the pink cell

gently resuspended with pasteur pipettes
ammonium chloride containing 45 mg/100 ml

in

isotonic (0.8 g/100 ml)

D-glucose at 20°C.

minutes sufficed to lyse remaining erythrocytes; the cell
were then centrifuged at 100 x g for 15 minutes at 4°C.
pellets were washed

in

pellets

Ten

suspensions
The cell

ice-cold Kreb's bicarbonate buffer at pH 7-4

(containing 45 mg/100 ml

D-glucose), centrifuged again at 100 x g for

15 minutes, and finally suspended in a volume of buffer sufficient for
the assays.

All

procedures were carried out

glass apparatus.

in plastic or nonwettable

Components of the buffer were as follows:

Na+

144.1 mEq/1

Cl"

130.6 mEq/1

K+

6.0 mEq/1

H2P04-

1.2 mEq/1

Ca++

6.8 mEq/1

SO^-

2.4 mEq/1

Mg++

2.4 mEq/1

HCO3"

25.1 mEq/1

0.1 ml

aliquots of cell

suspensions were diluted

in 1.9 ml

of 4% acetic acid for enumeration by hemocytometer under phase
microscopy.

Final

and 30 x 10^/ml.

concentrations of leukocytes were between 6 x 10^/ml

51-

-

Oxidation of 1 Ac~3~P rop i onate and ^C-1

Incubations were carried out

A-Succ i nate

in an apparatus developed by

O

Hsia,

shown

in Figure A.

Teflon tubes which fit snuggly into the

mouths of scintillation vials were modified for the assay by drilling
four holes of approximately 2 mm diameter about the perimeter of the
tube

(A,

Figure A).

The tubes were then

vials containing 0.5 ml
occluded by the vial

"Hyamine" alkali

necks.

1.65 mcmole

inserted

into scintillation

so that the holes were
(0.25-1.69 mcCi)

Na ^C-3-prop i onate or 1 .65 mcmole (0-34-1 .50 mcCi)
acid

(both purchased from New England Nuclear Co.)

of 0.1 ml was placed in each tube.
was added to each.

^C-1 , A-succ i n i c
in a total volume

0.9 ml of leukocyte suspension

The tubes were gassed for 1 minute with a 95% O2:

5% CO2 mixture, sealed with rubber stoppers (Figure AB) , and incubated
for three hours at 37°C in a Dubnoff metabolic shaker.
At the conclusion of the

incubation period,

^C02 formed from

l^C-labelled substrates was collected by placing the vials

in ice with

the tubes pushed about 0.5 cm farther into the vials, thus establishing
continuity between the gas phases of the sealed tubes and the vials,
and the reactions were terminated by injection of 1.0 ml of 6 N b^SO^
into the incubation mix (Figure AC) .

The evolved CO2 was collected

the Hyamine over 30 minutes, with a yield of at
apparatuses were disassembled,
England Nuclear)
^C02 counted

least 85%.^5

in

The

10 ml of toluene - Liquifluor (New

added to each vial

(Figure Ad) , and the radioactive

in a Packard liquid scintillation spectrometer.

were corrected for quenching by the channels ratios method.

Counts
Normal

con-

!

'!
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A

B

CD

Figure 4. Apparatus used for leukocyte oxidation of propionate
and succinate. Explanation of the legend can be found in the
text.
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trol

cells and cell-free blanks were run simultaneously with each

assay.

Results were calculated as nmoles of CO2 evolved from the

substrate over the 3 hour incubation per 10$ leukocytes.

Formation of ^C-L-Serine from L-Glycine and Na ^C-Formate

Assay conditions were modified from those described by
Ellegaard and Esmann.^

0.9 ml

of leukocyte suspensions were pipetted

into nonwettable glass scintillation vials containing 0.1 ml of
"formate substrate" such that final

incubation concentrations were

calculated to be glucose 6.6 mM, L-glycine 20 mM, and Na I^C-formate
(New England Nuclear Co., s.a. 58.6 mC/mmole)
were gassed for one minute with 95% O2:

41 nmoles/ml.

5% CO2, capped, and agitated

gently for four hours at 37°C in a Dubnoff shaker.
terminated by heating the vials for two minutes
Normal control

The vials

Incubations were

in a 95°C water bath.

cells and cell-free blanks were run simultaneously with

each assay.
After heating, the suspensions were transferred to glass
centrifuge tubes, centrifuged at 250 x g for 10 minutes, and portions
of the supernatants

removed for separation of ^C-L-serine.

Separation of ^C-L-Ser?ne from Na ^C-Formate

Serine was separated by a modification of the isoionic exchange
chromatographic technique described by Thauer et al..^

Columns

(l

cm

inside diameter) were filled with 1.5 g of moist resin

(Dowex 2-X8,

200-400 mesh), converted to formate from with 2 N ammonium formate.9
Initially, several eluent solutions were used.
2.0 ml

samples, acidified to a final

oacetic acid
ml

It was found that when

concentration of 0.01 N trichlor¬

(TCA) were applied to the columns and washed

in with 1.0

H2O and 1.0 ml of acid eluent, approximately 96% of applied

^C-L-serine appeared in the initial

4.0 ml of eluate

(Figure 5).

Elutions were continued with increasing concentrations of formic acid
or with 0.4 N sulphuric acid; with each of these

it was consistently

found that ^C-formate was retarded beyond the volume containing serine
(Figure 5).

For

routine assay, therefore, acidified 2.0 ml samples

were applied, washed

in with 1.0 ml

and the corresponding 4.0 ml
(1.0 ml

aliquots

in 9-0 ml

of H2O and 1.0 ml of 0.05 N HC00H,

collected and its radioactivity counted

of "Aquasol", New England Nuclear Co.).

Quench correction was by the channels ratios method.
the initial

4.0 ml

Radioactivity

in

eluate was assumed to be ^C-3-L-serine derived from

1^C-formate, and results were calculated as nmoles ^C-L-serine formed
per 1O^ leukocytes over the four hour incubation period.

aThauer125 prepared columns with 4 N ammonium formate.
The concentration
change was required to enable solubility of the initial column eluate
in scintillation cocktail.
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/ V
/

l
r
i

b

Figure 5.
Isoionic Exchange Chromatography of -^C-L-Serine and
Formate.
A: l^p-L-Serine, eluted with formic acid (0.05p Ci, 0.2 N HCOOH.
95.6 % of applied ^C-L-serine appeared in the
first 4.0 ml of eluate).
B: 14c-Formate, eluted with sulfuric acid. (0.6 pCi, eluted with
1.0 ml of 0.05 N HCOOII and 15.0 ml 0.4 N H?S04.
96.7 % of applied 14c_formate eluted as a discrete
peak).
C: l^c-poj^ate, eluted with formic acid (0.6 pCi, 0.2 N HCOOH. 93 %
of applied l^c-formate eluted as a discrete peak).
D:
eluted with dilute formic acid (0.6 pCi, 0.05 N
HCOOH. 12.9 % of applied l^C-formate had appeared
prior to cessation of collection at 35 ml).
N
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results

Studies of the Leukocyte Serine Hydroxymethylase Assay

in order to ascertain the effects of changes
I^C-formate concentration on net

in assay

incorporation into ^C-serine,

replicate assays were run with varying amounts of ^C-formate in the
incubation mixes, yielding the following results:

Na l^C-formate in
incubation mix

Cel 1

k3 nmoles

17-9 x

Count
106/ml

nmoles Ser
109 WBC
k hrs
10.5,

10.2

91 nmoles

13-8,

12.6

143 nmoles

15.6,

15.5

Since a more than threefold increase in

incubation l^C-formate concen¬

tration produced no more than a 50% increase in formation of radio¬
active serine,

it was concluded that at the concentrations tested,

formate concentration was not the rate-1imiting factor in total
incorporation.a
Activity of serine hydroxymethylase was also sought in diploid
human fibroblasts.

These cells proved to incorporate ^C-formate

into

serine at a rate approximately fifty times that observed in peripheral
1eukocytes.

aThis contrasts with the findings of Ellegaard and Esmann^3 who observed
a linear relationship between ^C-formate concentration and ^C~3~
serine formation in lymphocyte suspensions.
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In one preliminary experiment,

-

replicate leukocyte suspen¬

sions were incubated with and without added glycine in the substrate
solution.

In the absence of exogenous glycine,

^C-serine formation

was reduced by approximately 50%.a
To confirm the identity of the eluate fraction collected and
counted as

^C-serine, 3-0 ml of the initial

set of assays were taken to dryness

4.0 ml eluate from one

in a vaccum dessicator, 0.02 ml

(0.2 mcC) of 3H-L-Serine (New England Nuclear Co.) and 0.18 ml of
distilled water were added to each, and 0.1 ml of the resulting
solutions were spotted on Whatman 3MM chromatography paper.

This was

subjected to electrophoresis at 2500 volts for six hours, using 6%
formic acid as the mobile phase
bath.

in a petroleum distillate

The e1ectrophoretograms were cut

counted

(Varsol)

into 1 x H inch strips and

in "Liquif1uor"-toluene in a Packard Tri-Carb liquid

scintillation spectrometer with window widths and gains adjusted for
maximum
energy

(3h)

counting efficiency with minimal

contamination of the low

channel

It was found that no

peak appeared
a single

by

disintegrations.

in the electrophoretograms of cell-free blanks, and that
peak, migrating precisely with marker 3H-L-serine over

23 inches, appeared in the eluates from live cell

incubations.

As no

other peaks were detected, this confirmatory procedure was omitted
from routine assays.

aSimilar data was also obtained by Ellegaard and Esmann. 1 a

-
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Patients Studied

Pernicious anemia-A1:

A 59 year old Caucasian male cook seen in the emergency room
because of pleuritic chest pain and found incidentally to have a
high MCV.
Diagnosis based on demonstration of histamine-fast
achlorhydria and Schilling tests (Stage 1: 1.0% excretion;
Stage II: 10% excretion).

A2 :

An 8k year old Swedish-American widow with an anemia unresponsive
to iron therapy.
Diagnosis made on the basis of histamine-fast
achlorhydria and Schilling tests (0.8% excretion without intrinsic
factor; k.2% excretion with intrinsic factor).

A3:

A 60 year old Caucasian housewife, presumed to have pernicious
anemia on the basis of a Stage I Schilling test yielding only
1.3% excretion of the ingested isotope over 2k hours.

Other

deficient patients--

B1:

A kk year old woman with heterozygous /3-thalassemia admitted to
the hospital for drainage of a chronic subdural hematoma following
resection of an intracerebral meningioma.
She had been taking
oral diphenylhydantoin for 9 months at the time of study and had
been transfused with 2 units of packed red cells one week prior
to study.
Stage I Schilling test revealed normal absorption of
Bi2»
Her B^ deficiency was presumably a secondary phenomenon
produced by profound folate deficiency.

B2:

A k8 year old massively obese Caucasian woman with an undiagnosed
neurological disorder characterized by reduced motor function
below Cc; with intact sensory modalities in all four extremities.
At the time of study she was on a zero Calorie diet with daily
oral 5 mg PGA supplements.
Bone marrow aspiration, gastric
secretion studies, and Schilling tests were not performed on this
patient.
The etiology of her Bi2 deficiency is not established.

Folate deficiency-C1:

A 25 year old Caucasian woman with intractible temporal
epilepsy, taking oral diphenylhydantoin.

lobe

C2:

A k2 year old housewife admitted for hysterectomy because of a
myomatous uterus.
Dietary history was consistent with folate deprivation.
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Clinical

laboratory data on all

patients studied are summarized

-

in

Table 3-

Oxidation of ^C~3~P rop i onate and ^C~ 1 ,4-Succ i nate

As shown

in Table 4, patients with vitamin B|2 deficiency,

whether or not resultant from pernicious anemia, uniformly demonstrated
a substantia 1 1 y reduced capacity to oxidize ^C-Propionate to
lZfC02, consistent with
action.

impairment of the methylmalonyl-CoA mutase re¬

Oxidation of succinate by pernicious anemia patients was

slightly increased as compared to controls, but no significant dif¬
ference in succinate oxidation was observed between control

subjects

and B^2“deficient patients without pernicious anemia, or between con¬
trols and all

B]2"deficient subjects as a group.

Two folate deficient patients studied showed no measurable
defects

in oxidation of either propionate or succinate.

listed as Bi2 deficient, was
as wel1.

Her serum B1 2 level

Patient B1,

in addition profoundly folate deficient
rose spontaneously to 200 pg/ml within

48 hours of initiation of folate therapy.
Figure 6 contrasts the mean propionate oxidations of individual
B^ deficient subjects with the values observed among normal

controls.

Comparison with laboratory data from Table 3 illustrates that the degree
of impairment of the methylmalonyl-CoA mutase activity of leukocytes
does not seem to correlate with either the degree of anemia or the
severity of B]2 deficiency as measured by plasma B12 assay.

Upper limit” of normal folate values is not established.
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I ncorporat i on of ^C-Formate into ^C-L-Serine

deficient patients, taken as a group, demonstrated a
highly statistically significant reduction

in the capacity of their

leukocytes to incorporate I^C-formate into labelled serine (Table 5)•
This was not simply a result of concomitant "quantitative" folate
deficiency, since patient A3 had the greatest

individual

reduction

in

serine formation but the highest levels of red cell and plasma folates.
Of interest

is the fact that, judged by severity of anemia, her Bi2

deficiency was also the most profound among the pernicious anemia
patients.
The mean pre-treatment values for ^C-formate incorporation
into serine by individual

patients are illustrated in Figure 7-

An unanticipated finding was a rather striking correlation
observed between the reduction of propionate oxidation and

impairment

of serine formation by leukocytes of the B■)2 deficient patients.
This

is

illustrated

in Figure 8.

Only two patients with folate deficiency unaccompanied by
B12 deficiency were found for study.
of Glycine

-

Serine

As seen

in Table 5, no impairment

interconversion was detected.

patients were studied several

Both of these

days after admission to the hospital, and

the ingestion of a folate-rich diet may have restored this function to
normal

before the assays were performed.

Neither of these patients had

marrow aspirations or reticulocyte counts done prior to the day of
assay, and neither was anemic.

One additional

patient not listed

in

.

-
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Figure 7.
Incorporation of ^C-formate into ^C-L-serine by intact
leukocytes from controls and patients. Control data are presented
as mean _+ one standard deviation. Values for patients represent
the mean of the number of observations in parentheses. Subjects
are identified as follows:
+:
*:
°:

Patients with pernicious anemia
Other B-j? deficient patients
Folate deficient patients
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nmoles ^C-Ser/ 10^ WBC/ 4 hours

Figure 8. Correlation Between Serine Formation and
Propionate Oxidation among Bp Deficient Patients.
+: Pernicious anemia patients
*: Other Bp deficient patients

-
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Table 3 was also studied.
tropical

This was a 26 year old woman with non-

sprue who had had a plasma folate level

prior to study.

of 1.2 ng/ml one week

Serine hydroxymethy1ase activity of her leukocytes

was assessed on the third day of PGA therapy, at which time her serum
folate level was 24.6 ng/ml

and her RBC folate 130 ng/ml.

cyte count on the day of assay (5-4%)

Reticulo¬

indicated active response to

treatment, and

incorporation of formate

into serine was 9-8 nmoles/10^

cells/4 hours,

indistinguishable from normal

subjects.
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DISCUSSION

Oxidation of Propionate

in

Deficiency

In ruminants, the propionate - methylmalonate - succinate path¬
way (Figure 9)
other mammals

plays a significant role in energy metabolism, but
it appears to function principally

in

in the oxidative

catabolism, via the tricarboxylic acid cycle, of several of the
essential amino acids, odd-chain fatty acids, cholesterol, and thymine.
Depletion of vitamin B^, one of the cofactors
actions, has been shown to result in
methylmalonic acid.^
more direct

increased urinary excretion of

Recently, Contreras and Giorgio have presented

in vitro evidence of a reduction

coba1 amin-dependent methylmalonyl
deficiency.

in this series of re¬

In their studies,

in activity of the

CoA mutase consequent to vitamin B]2

leukocyte homogenates from patients with

pernicious anemia demonstrated a decreased capacity to oxidize racemic

1 4c (carboxy) methylmalonyl CoA to

This defect could be

partially overcome by addition of large amounts of the "missing" co¬
factor, dA-B^j to the homogenates.
of these findings.

Intact

The present studies confirm some

leukocytes from patients with vitamin Bi2

deficiency uniformly demonstrated a decreased capacity to oxidize

14c- 3-propionate to ^CC^.

That this diminished ^CC>2 production was

caused by depressed activity of methylmalonyl

CoA mutase is strongly

suggested by demonstration that oxidation of ^C-1,4-succinate was
normal or even

increased in all

patients studied.

No apparent cor-
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relation was observed between severity of Bi2 deficiency, as assessed
by the usual

indices of depletion

(mac rocytos i s, serum

level,

degree of anemia), and the magnitude of the reduction of propionate
oxidation.

Similar absence of such correlations were found by

Contreras and Giorgio, who also failed to demonstrate any relationship
between the magnitude of urinary methylama1onate excretion and the
severity of impairment of mutase activity.
The extremely high values for ^C-1 , A-succ i nate oxidation
seen

in one B-\2 deficient patient

in the present study may have

represented a chance phenomenon, but they could also be indicative of
the severity of the block in methy1ma1onate isomerization.
endogenous production of succinyl
methylmalonyl

If the

CoA were diminished by reduced

CoA mutase activity, exogenous ^C-succinate would con¬

stitute a greater fraction of the total
^CC^ production from this tracer.

pool,

As seen

resulting in

increased

in Figure 6, this hypothesis

tends to be supported by the data from the patients studied;

leukocytes

demonstrating the least severe impairment of propionate oxidation also
had the lowest values for

^CC>2 production from added

The number of patients studied

*^C-1 ,4-succ i nate.

is not large enough, however, to

attribute definite significance to this observation.
Contreras and Giorgio also studied the oxidation of methylmalonyl

CoA by homogenates of leukocytes from six patients with anemias

not attributable to vitamin B ^

2

deficiency (five with low serum folates,

and one with iron deficiency resulting from blood loss).
six demonstrated as severe a reduction

in methylmalonyl

Four of the
CoA oxidation
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as was observed

in leukocytes from pernicious anemia patients.

-

The

data from this group of patients are extremely difficult to interpret,
because of the absence of suitable controls demonstrating

integrity

of the remainder of the pathway leading to ^C02, and all of these
patients appeared to be severely ill.

Although five of the six were

"folate deficient" none could be considered representative of pure
nutritional

folate deficiency.

mutase activity is of interest

Nevertheless, the finding of reduced
in the light of the suggestion that

folate deficiency does lead to reduction of intracellular cobalamin
levels.^2

Measurement of urinary methylmalonate excretion would have

been of interest

in these patients, but this was not done.

In the

present studies, no impairment of propionate oxidation by intact
leukocytes from two folate deficient patients was observed.

Because

neither of these patients was anemic, direct comparisons with Contreras
and Giorgio's folate deficient subjects, all of whom had hemoglobin
levels less than 10 g/100 ml, are perhaps unjustifiable.

Succinate

oxidation seemed also to be unimpaired in the two folate deficient
patients studied here, which is at variance with the suggestion of
Degrazia et_ aj_.

that folate deficiency may for unknown reasons reduce

capacity for succinate oxidation

in v i vo. ^7

Contreras and Giorgio demonstrated that, under the conditions
of their assay, Bi2 deficient leukocyte homogenates were unable to
utilize CN-B12-

That

intact leukocytes can do so has

recently been

demonstrated in vitro in cells derived from B^ deficient pigs.^8
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Several

lines of evidence discussed earlier suggest that

integrity of the propionate pathway is not essential
topoeisis.

to normal

hema-

When pernicious anemia patients have been treated with B]2>

methylmalonate excretion^23 and

impaired

in vivo oxidation of

^C-2-propionate^9 have persisted for some time following establish¬
ment of hematologic remission.
methy1malonicacidemia,

In the inborn error of metabolism,

in which only this pathway is

impaired,

administration of methionine aggravates methylmalonate excretion,^30
but such an effect

is not observed

in pernicious anemia.^31

deficiency is thought to interfere with both pathways
the vitamin.

Exogenous

requiring

Since methionine is catabolized first by demethy1 ation

to homocysteine and then through the propionate pathway (Figure 8), no
increase in methylmalonate excretion would be expected to be provoked
by methionine administration to B-|2 deficient patients.

Formation of Serine in B]2 Deficiency

The present studies demonstrate a decreased capacity of
peripheral

leukocytes from patients with

blastosis to incorporate ^C-formate

deficiency and megalo-

into serine.

This strongly sup¬

ports the "methy1folate trap" hypothesis, since the most plausible
explanation of the finding is that B^ deficiency produced depletion of
free FH^ available to combine with the exogenous

^C-formate.

These

findings are in agreement with the observations of Metz et_ a_K , who
suggested that N^N ^-Ch^-FH^ pools were reduced

in B12 deficiency
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because of impaired deoxyuridine methylation by megaloblasts from
patients with pernicious anemia.97

The results of the present experi¬

ments also indicate that defective ^C-formate incorporation

into

serine cannot be considered a sensitive and specific index of folate
deficiency, as has been suggested by Ellegaard and Esmann.^

Contrary

to the claims of these authors, assessment of this function was not
found to be of value in the detection of minimal
Several

folate deficiency.

possible explanations for this discrepancy can be postulated.

Ellegaard and Esmann assayed formate incorporation by lymphocytes,
whereas the present studies were conducted on mixed leukocyte populations
containing approximately 75% granulocytes.
in the peripheral

circulation.

The latter are short-lived

Since the two folate deficient patients

studied here had been on hospital

diets for at

collection of blood for the assay,

it

least 3 days prior to

is conceivable that a new,

folate-repleted population of granulocytes may have appeared during
that

interval.

Since little is known about the kinetics of folate up¬

take and storage by polymorphonuclear

1eukocytes,132

it

may

be

justifiable to attribute the differences observed to the cell

un¬

types

studied.
Objections can be raised against the choice of formate as
the radioactive substrate in both of these studies.
NlO-CHO-FH^ requires ATP as well

as FH^ and formate.

Formation of
The equilibrium

for dehydration of N^CHO-FH^ to n5n 10-CH= FH^ lies far in the direction
of NlO-CHO-FH/j at physiologic pH.
n5n10-ch=fh2+

to methy1enefolate.^33

NADPH is required to reduce the
Formaldehyde, on the other hand,

reacts rapidly and non-enzymatica11y with FH^ to generate methylenefolate.

Formate was chosen as substrate solely because of the ease

with which

it could be separated from serine.

Implications and Unresolved

Taken

Issues

in concert, the studies of propionate oxidation and

glycine-serine interconversion here reported are consistent with the
currently accepted hypothesis of the metabolic effects of B]2
deficiency.
but

Folate-dependent metabolism was

impaired

in 812 deficiency,

dependent metabolism was unaffected by folate deficiency.

Recently, a new inborn error of metabolism has been recognized which
raises doubts about the hematologic significance of this now wellestablished

interaction of the two vitamins.

two infants with megaloblastic anemia
shown to be caused by congenital

Hakami et_ aj_. described

in the neonatal

period which was

deficiency of transcoba1 amin

^-globulin which seems to be important

II, the

in facilitating cellular B^

uptake.Both of these siblings responded to massive frequent Bj2
injections, but when B^ therapy was withdrawn in one, prompt relapse
into a profound megaloblastic anemia ensued within six weeks.

No

abnormalities of either known B]2"dependent reaction could be detected
well

after mega 1ob1astosis had developed.^35

It was suggested by the

authors that an as yet unappreciated role of Bi2 must be involved
the production of megalob1astosis.
the significance of these findings.

It

in

is difficult at present to assess

The assertion that both the mutase
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and transmethy1ase enzymes were continuing to function normally in the
face of unequivocal megaloblastosis was based on very gross
(lack of methylma1onate excretion, homocystine
plasma methionine).

indices

excretion, or fall

in

Nevertheless, the fact that pernicious anemia

patients treated with folate eventually relapse hematologica11y even
while on folic acid3!

suggests that more remains to be learned about

cobalamin-folate interactions.

In the light of the plasma/red cell

folate gradient observed

deficiency, the similar B]2 gradient

seen

in

in folate deficiency, and the sequence of metabolic events

occurring in development of anemia in transcoba1 amin

II

deficiency, a

search for interactions of cobalamins and folates at the cell membrane
might be productive.

A possible mechanism for B^2“dependent cell

folate uptake has just been suggested by Tisman and Herbert.^35
investigators found that marrow cell
was

uptake of 3h-] abel 1 ed N^CH^-FH^

impaired in megaloblasts from pernicious anemia patients, and that

uptake could be increased
Cell

These

10-30% by addition of CN-B-j2 to the cultures.

uptake of PGA was not significantly reduced

anemia patients and was not stimulated by CN-B^-

in the pernicious
The authors

speculated that a membrane-bound, B^2“dependent transmethylase might
play a role

in uptake of serum methylfolate and that reduced activity

of this enzyme

in B^ deficiency could account for the serum/cell

gradients seen

in pernicious anemia.

folate

The striking correlation observed in the present studies
between the degree of impairment of folate-dependent serine formation
and B-j2“dependent propionate oxidation among B12 deficient patients

*
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(Figure 8)

is consistent with a role for

Serine hydroxymethy1ase and methy1ma1ony1
cofactor requirements.
coenzymes for both;

<n cell

folate uptake.

CoA mutase share no known

The data therefore suggest that availability of

i.e., N^N^O-CP^-FH^ and dA-B^, way be limited

proportionately by a given degree of B^ deficiency.

This correlation

is not necessarily inconsistent with the methylfolate trap hypothesis.
If the rate-1 i mi t i ng step in B^ coenzyme formation were an early one
common to both CH3-B12 and dA-B]2>
expected.

the observed relationship might be

According to the hypothesis, serine formation is

indirectly

B ] 2"dependent, since the regeneration of FHzj requires the presence of
sufficient CH3-B12 to catalyze the homocysteine transmethy1ase re¬
action.

Proportionate depletion of both B12 coenzymes could

manner result
FH

in similar reductions

and hence N^N^(->-CH2 - FH ,4.

in the pool

Total

formation are influenced by many factors

in this

of free intracel1ular

production and ^C-serine
in addition to coenzyme

availability, such as the rates of apoenzyme synthesis and the affinities
of the apoenzymes for their substrates and cofactors.

The observed

proportionate impairment of these two metabolic functions

in a small

number of B12 deficient patients thus raises the need for further
studies to establish its metabolic basis.
One of the goals of the present undertaking was to achieve
simplification of Ellegaard and Esmann's rather tedious assay.
details were omitted from their brief report, they employed

Although

ion exchange

chromatography followed by metaperiodate oxidation of the isolated
serine, yielding ^CF^O specifically from the

|3~carbon of serine. ^37
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The modifications

introduced

in the present studies, although simpler,

may have diminished the specificity or sensitivity of the test.

The

results obtained here from study of only two folate deficient patients
must be regarded as extremely preliminary, requiring confirmation
larger series of patients.

in a

An alternative simplified metaperiodate

assay specific for the /3 -carbon of serine^S might be an appropriate
tool

to use in such future studies of glycine-serine interconversion

folate deficient patients.
to ascertain what,

in

One of the goals of such studies would be

if any, correlation exists between

integrity of the

glycine-serine pathway and other measures of body folate stores, such
as the red cell

folate.

It remains to be demonstrated whether or not

the assay here developed can be adapted as a clinically useful
folate deficiency.

Studies of glycine-serine interconversion

leukocytes from folate deficient patients
folate compounds might

reveal

area of folate transport

in

incubated

test of
in

intact

in vitro with various

information about the largely unexplored

leukocytes.

Future experiments might also

be directed towards assessment of the effects on

glycine-serine

inter-

conversion of anticonvu1sants and antifolate antimetabolites.
The demonstration of high levels of serine hydroxymethy1ase
activity in cultured fibroblasts suggests an alternative approach to
the study of cellular metabolism in Bj2 and folate deficiencies.
cells are known to contain homocysteine transmethylase1^
malonyl

These

and methyl-

CoA mutase,^^ and their uptake of vitamin B12 is stimulated

by Transcoba 1 ami n

II. ^39

Fibroblasts cultured with dialyzed sera in

selectively deficient media might yield a readily available,

reproducible,
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intact-cell

system in which coba1 amin-folate interrelationships could

be further elucidated.
Although the present work strongly suggests that alterations
in

intracellular folate pools occur consequent to vitamin B-j2 deficiency,

the roles played by such disturbances
will

in the genesis of megaloblastosis

not be conclusively elucidated until

more precisely measured.

the pools themselves can be
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